Joint association of Insulin resistance and frailty index with incident atherosclerotic cardiovascular disease (ASCVD) and major adverse cardiovascular events (MACE) in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a multi-cohort study

Cardiovasc DiabetolPublished Multi-cohort study

Authors' conclusion

The IR-FI are significantly associated with the incidence of cardiovascular events, an association that appears to be mediated through systemic inflammatory pathways.

Study context

Population
Individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0–3 from the UK Biobank and the China Health and Retirement Longitudinal Study (CHARLS)259,714 UK Biobank (UKB)
Exposure
Higher vs lower composite IR-FI indices
Outcome
UKB: incident ASCVD and MACE (co-primary)
Methodological detailsUK Biobank and CHARLS cohorts
  • UK Biobank and CHARLS cohorts

Main finding

As reported in the abstract

ASCVD and MACE (UKB)
  • Elevated IR-FI associated with increased risks of ASCVD and MACE in the UKB
  • Significant positive nonlinear relationships of METS-IR-FI and eGDR-FI with CV outcomes

Observational data: associations, not effects.

Secondary outcomes

CVD, heart disease and stroke (CHARLS)

Consistent findings for CVD, heart disease and stroke in the CHARLS

Mediation by inflammatory markers

C-reactive protein, neutrophils and leucocytes partially mediated the associations (ratio range)
1.5-12%

Proteomic analyses

Cytokine-cytokine receptor interaction identified as primary regulatory hub; leukocyte migration, chemotaxis and neutrophil degranulation as central pathological mechanisms

Original publication

Joint association of Insulin resistance and frailty index with incident ASCVD and MACE in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a multi-cohort study. Cardiovasc Diabetol. Published 6 July 2026. doi:10.1186/s12933-026-03275-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.